Skip to main content
. 2019 Jul 2;13:1037–1050. doi: 10.2147/PPA.S202173

Figure 2.

Figure 2

Proportion of de novo and rollover (RO) participants reporting satisfaction with RBP-7000, at active baseline (BL) and end of study (EOS). There was a 15% increase in satisfaction among all participants from baseline to end of study.